tiprankstipranks
Oyster Point Pharma Skyrockets on Viatris Deal
PremiumMarket NewsOyster Point Pharma Skyrockets on Viatris Deal
1y ago
Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
PremiumPress Releases
Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
1y ago
Viatris to acquire Oyster Point for $11 per share plus CVR up to $2.00 per share
PremiumThe Fly
Viatris to acquire Oyster Point for $11 per share plus CVR up to $2.00 per share
1y ago
Oyster Point Pharma Announces TYRVAYA® To Be Covered By the Largest Medicare Pharmacy Benefit Manager
PremiumPress ReleasesOyster Point Pharma Announces TYRVAYA® To Be Covered By the Largest Medicare Pharmacy Benefit Manager
2y ago
Oyster Point Pharma To Report Second Quarter 2022 Financial Results On August 11, 2022
PremiumPress Releases
Oyster Point Pharma To Report Second Quarter 2022 Financial Results On August 11, 2022
2y ago
2 “Strong Buy” Penny Stocks That Could Go Boom
PremiumStock Analysis & Ideas
2 “Strong Buy” Penny Stocks That Could Go Boom
2y ago
Oyster Point Pharma Research Selected for Top 5 Poster Session at American Optometric Association’s Optometry’s Meeting®
PremiumPress ReleasesOyster Point Pharma Research Selected for Top 5 Poster Session at American Optometric Association’s Optometry’s Meeting®
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100